The Incidence of Drug- and Herbal and Dietary Supplement-Induced Liver Injury: Preliminary Findings from Gastroenterologist-Based Surveillance in the Population of the State of Delaware

Drug Safety

Volumn 40, Issue 9, 2017, Pages 783-787

  Vega, Maricruz ^a   Verma, Manisha ^a   Beswick, David ^b   Bey, Stephanie ^b   Hossack, Jared ^c   Merriman, Nathan ^b   Shah, Ashish ^d   Navarro, Victor ^a  

^a EINSTEIN MEDICAL CENTER   (United States)

^b Gastroenterology Associates   (United States)

^c Mid Atlantic GI Consultants   (United States)

^d First State Gastroenterology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ANTIBIOTIC AGENT; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; PLANT MEDICINAL PRODUCT;

ABDOMINAL PAIN; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CAUCASIAN; CLINICAL ARTICLE; DELAWARE; DIETARY SUPPLEMENT; DISEASE SURVEILLANCE; DRUG SAFETY; EOSINOPHILIA; FEMALE; FEVER; GASTROENTEROLOGIST; HERBAL MEDICINE; HUMAN; INCIDENCE; JAUNDICE; LABORATORY; MALE; ONSET AGE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SIDE EFFECT; TOXIC HEPATITIS; HEALTH SURVEY; MIDDLE AGED; UNITED STATES; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; CHEMICAL AND DRUG INDUCED LIVER INJURY; DELAWARE; DIETARY SUPPLEMENTS; FEMALE; GASTROENTEROLOGISTS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PLANT PREPARATIONS; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; UNITED STATES; YOUNG ADULT;

EID: 85019765279     PISSN: 01145916     EISSN: 11791942     Source Type: Journal    
DOI: 10.1007/s40264-017-0547-9     Document Type: Article

References (13)

1. Larrey D. Epidemiology and individual susceptibility to adverse drug reactions affecting the liver. Semin Liv Dis. 2002;22(2):145–56.
2. Moride Y, Haramburu F, Requejo AA, Bégaud B. Under-reporting of adverse drug reactions in general practice. Br J Clin Pharmacol. 1997;43(2):177–81.
3. Sgro C, Clinard F, Ouazir K, Chanay H, Allard C, Guilleminet C, et al. Incidence of drug-induced hepatic injuries: a French population-based study. Hepatology. 2002;36(2):451–5.
4. De Valle MB, Av Klinteberg V, Alem N, Olsson R, Björnsson E. Drug-induced liver injury in a Swedish University hospital out-patient hepatology clinic. Aliment Pharmacol Ther. 2006;24(8):1187–95.
5. de Abajo FJ, Montero D, Madurga M, García Rodríguez LA. Acute and clinically relevant drug-induced liver injury: a population based case–control study. Br J Clin Pharmacol. 2004;58(1):71–80.
6. Goldberg DS, Forde KA, Carbonari DM, Lewis JD, Leidi KB, Reddy KR, et al. Population-representative incidence of drug-induced acute liver failure based on an analysis of integrated healthcare system. Gastroenterology. 2015;148(7):1353–61.
7. Galan MV, Potts JA, Silverman AL, Gordon SC. The burden of acute nonfulminant drug-induced hepatitis in a United States tertiary referral center. J Clin Gastroenterol. 2005;39(1):64–7.
8. Vuppalanchi R, Liangpunsakul S, Chalasani N. Etiology of new-onset jaundice: how often is it caused by idiosyncratic drug-induced liver injury in the United States? Am J Gastroenterol. 2007;102(3):558–62.
9. Björnsson ES, Bergmann OM, Björnsson HK, Kvaran RB, Olafsson S. Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland. Gastroenterology. 2013;144(7):1419–25.
10. Fontana RJ, Watkins PB, Bonkovsky HL, Chalasani N, Davern T, Serrano J, DILIN Study Group, et al. Drug-induced liver injury network (DILIN) prospective study: rationale, design and conduct. Drug Saf. 2009;32(1):55–68.
11. United States Census Bureau, Population Division [Internet], Table 1. Annual Estimates of the Resident Population for the United States, Regions, States, and Puerto Rico: April 1, 2010 to July 1, 2016 (NST-EST2016-01). 2016. https://www.census.gov/data/tables/2016/demo/popest/state-detail.html. Accessed 19 Sept 2016.
12. United States Census Bureau [Internet]. American Fact Finder. 2014. https://factfinder.census.gov/faces/nav/jsf/pages/community_facts.xhtml. Accessed 19 Sept 2016.
13. Navarro VJ, Barnhart H, Bonkovsky HL, Davern T, Fontana RJ, Grant L, et al. Liver injury from herbals and dietary supplements in the US drug-induced liver injury network. Hepatology. 2014;60(4):1399–408.